<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0549539" disease_type="Disease or Syndrome" abbrv="">Bone marrow abnormalities</z:e> may be found in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> even without marrow <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We have seen that patients with non-hematologic <z:hpo ids='HP_0002664'>neoplasias</z:hpo> may show bone remodelling, stromal modifications, reactive changes and myelodysplastic alterations of erythro-, granulo- and megakaryocytic series comparable to those found in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: At the beginning of the study 58 bone marrow biopsies (BMBs), performed in 40 patients with previously diagnosed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> from different primary sites but without marrow <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (group A), were evaluated </plain></SENT>
<SENT sid="3" pm="."><plain>Osseous and stromal modifications, marked reactive changes, quantitative and qualitative alterations of erythro-, granulo- and megakaryopoiesis were observed </plain></SENT>
<SENT sid="4" pm="."><plain>Afterwards, 30 BMBs from 20 patients without a previous diagnosis of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (group B) were found to have features similar to those discovered in group A </plain></SENT>
<SENT sid="5" pm="."><plain>Further investigations detected <z:mp ids='MP_0002018'>malignant tumors</z:mp> in <z:hpo ids='HP_0000001'>all</z:hpo> these cases </plain></SENT>
<SENT sid="6" pm="."><plain>The findings of the two groups were compared with our former observations on <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The main differences between groups A-B and MDSs regarded bone remodelling, stromal modifications and reactive changes </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: These marrow alterations linked to a <z:hpo ids='HP_0002664'>neoplasia</z:hpo> may be considered paraneoplastic </plain></SENT>
<SENT sid="9" pm="."><plain>They may cause problems for a differential diagnosis with some proliferative diseases and, above <z:hpo ids='HP_0000001'>all</z:hpo>, with primary MDSs </plain></SENT>
<SENT sid="10" pm="."><plain>The reported features should prompt the pathologist to suggest a search for possible occult <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>